SCYX · Scynexis Inc
$3.77
+0.14 (+3.72%)
At close · Jul 29
Market Cap
$288.38M
Shares
79.44M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Dr. David Angulo | CEO | $1,540,181 |
| Ivor Macleod | CFO | $859,162 |
| Scott Sukenick | Chief Legal Officer | $833,015 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Dr. David Angulo | CEO | $2,027,854 |
| Ivor Macleod | CFO | $1,186,129 |
| Scott Sukenick | Chief Legal Officer | $1,176,130 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Dr. David Angulo | CEO | $1,214,710 |
| Scott Sukenick | Chief Legal Officer | $936,697 |
| Ivor Macleod | CFO | $626,896 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Marco Taglietti | CEO | $2,608,785 |
| Dr. David Angulo | CEO | $1,168,835 |
| Christine Coyne | Chief Commercial Officer | $1,164,197 |
| Scott Sukenick | Chief Legal Officer | $976,807 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Marco Taglietti | CEO | $1,714,217 |
| Christine Coyne | Chief Commercial Officer | $1,033,194 |
| Dr. David Angulo | CEO | $987,475 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Marco Taglietti | CEO | $1,449,548 |
| Dr. David Angulo | Chief Medical Officer | $938,803 |
| Eric Francois | CFO | $825,198 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Marco Taglietti | CEO | $1,534,585 |
| Dr. David Angulo | Chief Medical Officer | $1,011,106 |
| Eric Francois | CFO | $884,057 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Marco Taglietti | CEO | $1,114,895 |
| Dr. David Angulo | Chief Medical Officer | $768,611 |
| Eric Francois | CFO | $664,701 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Steven C. Gilman | member of the Board of Directors | Retired | 2026-04-20 |